loadpatents
Patent applications and USPTO patent grants for CLOZEL; Martine.The latest application filed is for "combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases".
Patent | Date |
---|---|
Combinations Of A 4-pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases App 20220064149 - BELLET; Marc ;   et al. | 2022-03-03 |
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Grant 11,174,247 - Bellet , et al. November 16, 2 | 2021-11-16 |
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist App 20210338640 - CLOZEL; Martine ;   et al. | 2021-11-04 |
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Grant 11,155,535 - Bellet , et al. October 26, 2 | 2021-10-26 |
Therapeutic Compositions App 20210177849 - Clozel; Martine | 2021-06-17 |
Pharmaceutical combination comprising a selective S1P1 receptor agonist Grant 11,026,927 - Clozel , et al. June 8, 2 | 2021-06-08 |
Therapeutic Compositions App 20200352944 - Clozel; Martine | 2020-11-12 |
Pharmaceutical Combination Comprising Ponesimod App 20200069655 - CLOZEL; Martine ;   et al. | 2020-03-05 |
Combinations Of A 4-pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases App 20200061061 - BELLET; Marc ;   et al. | 2020-02-27 |
Therapeutic Compositions App 20200038401 - Clozel; Martine | 2020-02-06 |
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist App 20190175563 - CLOZEL; Martine ;   et al. | 2019-06-13 |
Pharmaceutical combination comprising a selective S1P1 receptor agonist Grant 10,245,253 - Clozel , et al. | 2019-04-02 |
Therapeutic Compositions App 20190083494 - Clozel; Martine | 2019-03-21 |
Therapeutic Compositions App 20180147205 - CLOZEL; Martine | 2018-05-31 |
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist App 20170348287 - CLOZEL; Martine ;   et al. | 2017-12-07 |
Therapeutic compositions containing macitentan Grant 9,597,331 - Clozel March 21, 2 | 2017-03-21 |
Therapeutic Compositions Containing Macitentan App 20160022678 - CLOZEL; Martine | 2016-01-28 |
Therapeutic Compositions Containing Macitentan App 20140329824 - CLOZEL; MARTINE | 2014-11-06 |
Therapeutic compositions containing macitentan Grant 8,809,334 - Clozel August 19, 2 | 2014-08-19 |
Therapeutic Compositions App 20140148460 - CLOZEL; Martine | 2014-05-29 |
Combination Comprising Paclitaxel For Treating Ovarian Cancer App 20130317048 - Clozel; Martine ;   et al. | 2013-11-28 |
Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer Grant 8,541,433 - Clozel , et al. September 24, 2 | 2013-09-24 |
Therapeutic Compositions App 20130210830 - CLOZEL; Martine | 2013-08-15 |
Therapeutic Compositions App 20130005734 - CLOZEL; Martine | 2013-01-03 |
Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor Grant 8,268,847 - Clozel September 18, 2 | 2012-09-18 |
Therapeutic Compositions Containing Macitentan App 20110136818 - Clozel; Martine | 2011-06-09 |
Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases Grant 7,868,012 - Bolli , et al. January 11, 2 | 2011-01-11 |
Combination Comprising Paclitaxel for Treating Ovarian Cancer App 20100311774 - Clozel; Martine ;   et al. | 2010-12-09 |
Substituted 1,2,3,4-tetrahydroisoquinoline Derivatives App 20100256182 - Aissaoui; Hamed ;   et al. | 2010-10-07 |
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives Grant 7,763,638 - Aissaoui , et al. July 27, 2 | 2010-07-27 |
Pyridine derivatives Grant 7,750,161 - Bur , et al. July 6, 2 | 2010-07-06 |
Thiophene derivatives Grant 7,750,040 - Bolli , et al. July 6, 2 | 2010-07-06 |
Endothelin Receptor Antagonists For Early Stage Idiopathic Pulmonary Fibrosis App 20100022568 - Clozel; Martine ;   et al. | 2010-01-28 |
Therapeutic Compositions Comprising a Specific Endothelin Receptor Antagonist and a PDE5 Inhibitor App 20090318459 - Clozel; Martine | 2009-12-24 |
Quinoxalin-3-one derivatives as orexin receptor antagonists Grant 7,538,109 - Aissaoui , et al. May 26, 2 | 2009-05-26 |
Pyrimidine-sulfamides and their use as endothelian receptor antagonist Grant 7,452,896 - Bolli , et al. November 18, 2 | 2008-11-18 |
Sulfonylamino-acetic acid derivatives Grant 7,435,815 - Aissaoui , et al. October 14, 2 | 2008-10-14 |
Quinoline derivatives Grant 7,375,227 - Aissaoui , et al. May 20, 2 | 2008-05-20 |
Novel Thiophene Derivatives App 20080064740 - Bolli; Martin ;   et al. | 2008-03-13 |
Alkansulfonamides as endothelin antagonists Grant 7,323,465 - Bolli , et al. January 29, 2 | 2008-01-29 |
Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases App 20080004298 - Bolli; Martin ;   et al. | 2008-01-03 |
Sulfamides and their use as endothelin receptor antagonists Grant 7,285,549 - Bolli , et al. October 23, 2 | 2007-10-23 |
Sulfonylamino-acetic Acid Derivatives App 20070244156 - Aissaoui; Hamed ;   et al. | 2007-10-18 |
Sulfonylamino-acetic acid derivatives Grant 7,279,578 - Aissaoui , et al. October 9, 2 | 2007-10-09 |
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives App 20070191424 - Aissaoui; Hamed ;   et al. | 2007-08-16 |
Novel sulfamides App 20070167472 - Bolli; Martin ;   et al. | 2007-07-19 |
Benzo-fused heterocycles as endothelin antagonists Grant 7,238,685 - Bolli , et al. July 3, 2 | 2007-07-03 |
Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists Grant 7,192,950 - Aissaoui , et al. March 20, 2 | 2007-03-20 |
Novel pyridine derivatives App 20070043081 - Bur; Daniel ;   et al. | 2007-02-22 |
Quinoxalinone-3-one derivatives as orexin receptor antagonists App 20070027157 - Aissaoui; Hamed ;   et al. | 2007-02-01 |
Novel piperidine derivatives App 20070010516 - Aissaoui; Hamed ;   et al. | 2007-01-11 |
Piperazine-alkyl-ureido derivatives App 20060211707 - Aissaoui; Hamed ;   et al. | 2006-09-21 |
Sulfamides and their use as endothelin receptor antagonists Grant 7,094,781 - Bolli , et al. August 22, 2 | 2006-08-22 |
Arylalkane-sulfonamides having endothelin-antagonist activity Grant 7,091,201 - Weller , et al. August 15, 2 | 2006-08-15 |
Novel sulfamides App 20060178365 - Bolli; Martin ;   et al. | 2006-08-10 |
Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists App 20060178515 - Aissaoui; Hamed ;   et al. | 2006-08-10 |
7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives Grant 7,067,519 - Aissaoui , et al. June 27, 2 | 2006-06-27 |
1-Pyridin-4-yl-urea derivatives App 20060094716 - Aissaoui; Hamed ;   et al. | 2006-05-04 |
Sulfonylamino-acetic acid derivatives App 20060014783 - Aissaoui; Hamed ;   et al. | 2006-01-19 |
Arylethene-sulfonamides Grant 6,951,856 - Boss , et al. October 4, 2 | 2005-10-04 |
Novel benzo-fused heterocycles as endothelin antagonisits App 20050124605 - Bolli, Martin ;   et al. | 2005-06-09 |
Novel alkansulfonamides as endothelin antagonists App 20050085639 - Bolli, Martin ;   et al. | 2005-04-21 |
4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists App 20050043535 - Aissaoui, Hamed ;   et al. | 2005-02-24 |
7 8 9 10-tetrahydro-6h-azepino, 6 7 8 9-tetrahydro-pyrido and 2 3-dihydro-2h-pyrrolo[2 1-b]-quinazolinone derivates App 20050009852 - Aissaoui, Hamed ;   et al. | 2005-01-13 |
1,2,3,4-tetrahydroisoquinolines derivatives App 20040242564 - Velker, Jorg ;   et al. | 2004-12-02 |
1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists Grant 6,815,451 - Velker , et al. November 9, 2 | 2004-11-09 |
1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists App 20040110744 - Velker, Jorg ;   et al. | 2004-06-10 |
Arylalkane-sulfonamides having endothelin-antagonist activity App 20040102464 - Weller, Thomas ;   et al. | 2004-05-27 |
Novel sulfamides and their use as endothelin receptor antagonists App 20040077670 - Bolli, Martin ;   et al. | 2004-04-22 |
Butyne diol derivatives Grant 6,720,322 - Bolli , et al. April 13, 2 | 2004-04-13 |
Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists App 20040058912 - Aissaoui, Hamed ;   et al. | 2004-03-25 |
1,2,3,4-tetrahydroisoquinoline derivatives Grant 6,703,392 - Aissaoui , et al. March 9, 2 | 2004-03-09 |
Novel arylethene-sulfonamides App 20030220359 - Boss, Christoph ;   et al. | 2003-11-27 |
1,2,3,4-tetrahydroisoquinoline derivatives App 20030176415 - Aissaoui, Hamed ;   et al. | 2003-09-18 |
6 alkoxy-4-pyrimidinyl bis-sulfonamides Grant 6,596,719 - Bolli , et al. July 22, 2 | 2003-07-22 |
Butyne diol derivatives App 20030087920 - Bolli, Martin ;   et al. | 2003-05-08 |
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists Grant 6,133,442 - Breu , et al. October 17, 2 | 2000-10-17 |
Sulfonamides Grant 6,004,965 - Breu , et al. December 21, 1 | 1999-12-21 |
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists Grant 5,962,682 - Breu , et al. October 5, 1 | 1999-10-05 |
Sulfonylaminopyrimidine carboxylic acid derivatives having endothelin inhibiting activity Grant 5,856,484 - Breu , et al. January 5, 1 | 1999-01-05 |
Sulphonamides Grant 5,837,708 - Breu , et al. November 17, 1 | 1998-11-17 |
Sulfonylaminopyrimidines Grant 5,541,186 - Breu , et al. July 30, 1 | 1996-07-30 |
Phenylsulfonylamide pyrimidine Grant 5,420,129 - Breu , et al. May 30, 1 | 1995-05-30 |
Sulfonamides Grant 5,292,740 - Burri , et al. March 8, 1 | 1994-03-08 |
Sulfonamides and uses Grant 5,270,313 - Burri , et al. December 14, 1 | 1993-12-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.